Elanco Animal Health (ELAN) Director Acquires $628,600.00 in Stock
Elanco Animal Health (NASDAQ:ELAN) Director R David Hoover bought 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The shares were acquired at an average cost of $31.43 per share, with a total value of $628,600.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Elanco Animal Health stock opened at $30.64 on Friday. Elanco Animal Health has a 52 week low of $28.00 and a 52 week high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last released its earnings results on Wednesday, February 6th. The company reported $0.29 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The business had revenue of $799.30 million for the quarter, compared to analysts’ expectations of $804.07 million. The business’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.12 earnings per share.
Several brokerages have issued reports on ELAN. Credit Suisse Group reaffirmed a “hold” rating and issued a $33.00 price objective on shares of Elanco Animal Health in a research report on Friday, January 4th. Zacks Investment Research raised shares of Elanco Animal Health from a “hold” rating to a “buy” rating and set a $36.00 price objective for the company in a research report on Monday, December 17th. Morgan Stanley began coverage on shares of Elanco Animal Health in a research report on Wednesday. They issued an “equal weight” rating and a $34.00 price objective for the company. Argus began coverage on shares of Elanco Animal Health in a research report on Tuesday, January 15th. They issued a “buy” rating and a $37.00 price objective for the company. Finally, BMO Capital Markets lowered their price objective on shares of Elanco Animal Health from $37.00 to $32.00 and set a “market perform” rating for the company in a research report on Wednesday, December 19th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $33.48.
ILLEGAL ACTIVITY WARNING: “Elanco Animal Health (ELAN) Director Acquires $628,600.00 in Stock” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://theolympiareport.com/2019/03/17/elanco-animal-health-elan-director-acquires-628600-00-in-stock.html.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Read More: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.